Skip to main content
Top

Current Treatment Options in Oncology

Issue 5/2024

Content (8 Articles)

HER2-Positive Metastatic Colorectal Cancer

Hannah R. Robinson, Wells A. Messersmith, Robert W. Lentz

Correction to: Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer

Andrew M. Fang, Jamaal Jackson, Justin R. Gregg, Lisly Chery, Chad Tang, Devaki Shilpa Surasi, Bilal A. Siddiqui, Soroush Rais-Bahrami, Tharakeswara Bathala, Brian F. Chapin

Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?

Alexander F. Wang, Brian Hsueh, Bryan D. Choi, Elizabeth R. Gerstner, Gavin P. Dunn

Open Access Anthracycline

Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods

Ziyu Kuang, Miao Kong, Ningzhe Yan, Xinyi Ma, Min Wu, Jie Li

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine